Evidence map›Paper›PMID 19329793›Full record

ReviewThe Journal of biological chemistry2009

DNA ligases: progress and prospects.

Stewart Shuman

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Fidelity of DNA ligase I is sensitive to physiological MgThe Journal of biological chemistry · 2026
    Article
  3. Article
  4. Article
  5. Brief guide to gene cloning.Molecules and cells · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. How advancements in molecular biology impact education and training.Journal of microbiology & biology education · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Apprehending the NADViruses · 2022
    Article
  16. Article
  17. Fueling genome maintenance: On the versatile roles of NADThe Journal of biological chemistry · 2022
    Review
  18. Article
  19. Anti-Interference Detection ofFoods (Basel, Switzerland) · 2022
    Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Stewart ShumanMolecular Biology Program, Sloan-Kettering Institute, New York, New York 10065, USA. s-shuman@ski.mskcc.org
Kettering University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA ligases seal 5'-PO4 and 3'-OH polynucleotide ends via three nucleotidyl transfer steps involving ligase-adenylate and DNA-adenylate intermediates. DNA ligases are essential guardians of genomic integrity, and ligase dysfunction underlies human genetic disease syndromes. Crystal structures of DNA ligases bound to nucleotide and nucleic acid substrates have illuminated how ligase reaction chemistry is catalyzed, how ligases recognize damaged DNA ends, and how protein domain movements and active-site remodeling are used to choreograph the end-joining pathway. Although a shared feature of DNA ligases is their envelopment of the nicked duplex as a C-shaped protein clamp, they accomplish this feat by using remarkably different accessory structural modules and domain topologies. As structural, biochemical, and phylogenetic insights coalesce, we can expect advances on several fronts, including (i) pharmacological targeting of ligases for antibacterial and anticancer therapies and (ii) the discovery and design of new strand-sealing enzymes with unique substrate specificities.

Indexed as

DNA LigasesHumansDNA Ligases

Identifiers

PMID19329793
PMCPMC2719376
OpenAlexW1967354453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.